Neurology 2003;60:1525-1527
© 2003 American Academy of Neurology
Brief Communications
Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke
M. D. Hill, MD FRCPC,
T. Lye, BA,
H. Moss, BA,
P. A. Barber, MB ChB, MRCP(UK),
A. M. Demchuk, MD FRCPC,
N. J. Newcommon, RN MSc,
T. L. Green, RN MA,
C. Kenney, RN,
A. ColeHaskayne, RN and
A. M. Buchan, BM FRCP
From the Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, Alberta, Canada.
Address correspondence and reprint requests to Dr. Michael D. Hill, Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, 1403 29 St. NW, Rm.1242A, Calgary, Alberta, Canada T2N 2T9; e-mail: michael.hill{at}calgaryhealthregion.ca
One hundred seventy-six consecutive patients treated with IV tissue plasminogen activator (tPA) for acute ischemic stroke were examined prospectively, and orolingual angioedema was found in nine (5.1%; 95% CI 2.3 to 9.5). The reaction was typically mild, transient, and contralateral to the ischemic hemisphere. Risk of angioedema was associated with angiotensin-converting enzyme inhibitors (relative risk [RR] 13.6; 95% CI 3.0 to 62.7) and signs on initial CT of ischemia in the insular and frontal cortex (RR 9.1; 95% CI 1.4 to 30.0).
This article has been cited by other articles:

|
 |

|
 |
 
D. Summers, A. Leonard, D. Wentworth, J. L. Saver, J. Simpson, J. A. Spilker, N. Hock, E. Miller, P. H. Mitchell, and on behalf of the American Heart Association Counci
Comprehensive Overview of Nursing and Interdisciplinary Care of the Acute Ischemic Stroke Patient: A Scientific Statement From the American Heart Association
Stroke,
August 1, 2009;
40(8):
2911 - 2944.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Alberts, R. A. Felberg, L. R. Guterman, S. R. Levine, and for Writing Group 4
Atherosclerotic Peripheral Vascular Disease Symposium II: Stroke Intervention: State of the Art
Circulation,
December 16, 2008;
118(25):
2845 - 2851.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Caplan
Stroke Thrombolysis: Slow Progress
Circulation,
July 18, 2006;
114(3):
187 - 190.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Rafii, M. Koenig, and W. C. Ziai
Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke
Neurology,
December 27, 2005;
65(12):
1906 - 1906.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Hill and J. D. Bisognano
Leukoaraiosis: The brain under pressure: Target for treatment?
Neurology,
June 14, 2005;
64(11):
1832 - 1833.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Hill, A. M. Buchan, and for The Canadian Alteplase for Stroke Effectivenes
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study
Can. Med. Assoc. J.,
May 10, 2005;
172(10):
1307 - 1312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Adams, R. Adams, G. Del Zoppo, and L. B. Goldstein
Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association
Stroke,
April 1, 2005;
36(4):
916 - 923.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
May 13 Highlights
Neurology,
May 13, 2003;
60(9):
1403 - 1405.
[Full Text]
[PDF]
|
 |
|
|